97 related articles for article (PubMed ID: 20843710)
1. Clinical features and prognosis of patients with renal cancer and a second malignancy.
Antonelli A; Calza S; Arrighi N; Zani D; Corti S; Cozzoli A; Zanotelli T; Cunico SC; Simeone C
Urol Oncol; 2012; 30(3):294-300. PubMed ID: 20843710
[TBL] [Abstract][Full Text] [Related]
2. Multiple primary malignancies in patients with renal cell carcinoma: a national population-based cohort study.
Beisland C; Talleraas O; Bakke A; Norstein J
BJU Int; 2006 Apr; 97(4):698-702. PubMed ID: 16536756
[TBL] [Abstract][Full Text] [Related]
3. De novo renal cell carcinoma of native kidney in renal transplant recipients.
Neuzillet Y; Lay F; Luccioni A; Daniel L; Berland Y; Coulange C; Lechevallier E
Cancer; 2005 Jan; 103(2):251-7. PubMed ID: 15593084
[TBL] [Abstract][Full Text] [Related]
4. Multiple primary malignancies in renal cell carcinoma.
Rabbani F; Grimaldi G; Russo P
J Urol; 1998 Oct; 160(4):1255-9. PubMed ID: 9751330
[TBL] [Abstract][Full Text] [Related]
5. Patients with colorectal and renal cell carcinoma diagnoses appear to be at risk for additional malignancies.
Steinhagen E; Moore HG; Lee-Kong SA; Shia J; Eaton A; Markowitz AJ; Russo P; Guillem JG
Clin Colorectal Cancer; 2013 Mar; 12(1):23-7. PubMed ID: 23026110
[TBL] [Abstract][Full Text] [Related]
6. The effect of bilaterality, pathological features and surgical outcome in nonhereditary renal cell carcinoma.
Blute ML; Itano NB; Cheville JC; Weaver AL; Lohse CM; Zincke H
J Urol; 2003 Apr; 169(4):1276-81. PubMed ID: 12629342
[TBL] [Abstract][Full Text] [Related]
7. Aspects of survival from colorectal cancer in Denmark.
Iversen LH
Dan Med J; 2012 Apr; 59(4):B4428. PubMed ID: 22459726
[TBL] [Abstract][Full Text] [Related]
8. The impact of temporal presentation on clinical and pathological outcomes for patients with sporadic bilateral renal masses.
Boorjian SA; Crispen PL; Lohse CM; Leibovich BC; Blute ML
Eur Urol; 2008 Oct; 54(4):855-63. PubMed ID: 18487007
[TBL] [Abstract][Full Text] [Related]
9. The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.
Ward JF; Blute ML; Cheville JC; Lohse CM; Weaver AL; Zincke H
J Urol; 2002 Jul; 168(1):56-60. PubMed ID: 12050492
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
Haferkamp A; Bastian PJ; Jakobi H; Pritsch M; Pfitzenmaier J; Albers P; Hallscheidt P; Müller SC; Hohenfellner M
J Urol; 2007 May; 177(5):1703-8. PubMed ID: 17437789
[TBL] [Abstract][Full Text] [Related]
11. [Clinical features and prognosis of multiple primary tumors of lung combined with other organs--report of 281 cases].
Yi SZ; Zhang DC; Wang YG; Sun KL
Ai Zheng; 2006 Jun; 25(6):731-5. PubMed ID: 16764770
[TBL] [Abstract][Full Text] [Related]
12. [Second primary malignant tumors in patients with primary renal cell carcinoma].
Turkić M; Znaor A; Novosel I; Reljić A; Belicza M; Kruslin B
Acta Med Croatica; 2005; 59(2):91-5. PubMed ID: 15909881
[TBL] [Abstract][Full Text] [Related]
13. Second primary malignancies associated with renal cell carcinoma histological subtypes.
Thompson RH; Leibovich BC; Cheville JC; Webster WS; Lohse CM; Kwon ED; Zincke H; Blute ML
J Urol; 2006 Sep; 176(3):900-3; discussion 903-4. PubMed ID: 16890648
[TBL] [Abstract][Full Text] [Related]
14. Bilateral breast carcinoma: risk factors and outcomes for patients with synchronous and metachronous disease.
Heron DE; Komarnicky LT; Hyslop T; Schwartz GF; Mansfield CM
Cancer; 2000 Jun; 88(12):2739-50. PubMed ID: 10870056
[TBL] [Abstract][Full Text] [Related]
15. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
16. Seasonal and geographical variations in lung cancer prognosis in Norway. Does Vitamin D from the sun play a role?
Porojnicu AC; Robsahm TE; Dahlback A; Berg JP; Christiani D; Bruland OS; Moan J
Lung Cancer; 2007 Mar; 55(3):263-70. PubMed ID: 17207891
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
18. Association of thyroid, breast and renal cell cancer: a population-based study of the prevalence of second malignancies.
Van Fossen VL; Wilhelm SM; Eaton JL; McHenry CR
Ann Surg Oncol; 2013 Apr; 20(4):1341-7. PubMed ID: 23263698
[TBL] [Abstract][Full Text] [Related]
19. Synchronous and metachronous malignancies: analysis of the Minneapolis Veterans Affairs (VA) tumor registry.
Powell S; Tarchand G; Rector T; Klein M
Cancer Causes Control; 2013 Aug; 24(8):1565-73. PubMed ID: 23737025
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
Yoo C; Song C; Hong JH; Kim CS; Ahn H
J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]